New Therapies For Fibromyalgia

Reporter: Ann Komis

Web Producer: Kerry Corum

Five to ten million Americans suffer from Fibromyalgia.

It's a condition characterized by extreme pain and muscle stiffness. It's often treated with anti-depressants.

Now, newer more targeted therapies may soon be available.

For more than 20 years, Elizabeth Tross-Deamer suffered the pain of Fibromyalgia.

She started taking a new medication called Pregabalin, and her pain subsided.

She says, "The memory is better. My relationships are better. People like me a lot more."

For the first time in years, this wine author can sleep at night, giving her back energy and stamina during the day.

Bernadine Smith took a different drug called Milnacipran, and had similar results. She says, "I didn't have as much depression. I wasn't as fatigued."

Dr. Philip Mease is testing both drugs, in separate studies. He says, "At least a third of the patients in both trials, have experienced, roughly, a 50-percent reduction in pain."

The drugs come from different families, Pregabalin is a pain reliever, Milnacipran an anti-depressant.

Dr Mease says,"What both of these medications are doing, are restoring to a more natural balance the neuro-chemicals in the brain that are off kilter, in this condition."

Both drugs are still in trials, but for these two women, the verdict is already in.

The most common side effects in the trial were mild dizziness and nausea.